Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free CGEN Stock Alerts

Compugen (CGEN) Financials

Compugen logo
$2.39 -0.08 (-3.24%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$2.38 -0.02 (-0.63%)
As of 07/10/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Compugen

Annual Income Statements for Compugen

This table shows Compugen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -20 -32 -37 -23 -27 -30 -34 -34 -19 -14 35
Consolidated Net Income / (Loss)		 -20 -32 -37 -23 -27 -30 -34 -34 -19 -14 35
Net Income / (Loss) Continuing Operations		 -20 -32 -37 -23 -27 -30 -34 -34 -19 -14 35
Total Pre-Tax Income 		-20 -31 -37 -23 -28 -30 -34 -34 -9.78 -9.71 35
Total Operating Income		 -21 -33 -37 -23 -29 -31 -35 -35 -13 -15 31
Total Gross Profit		 7.64 0.49 0.00 17 0.00 1.94 5.32 6.53 31 20 64
Total Revenue		 9.28 0.71 0.00 18 0.00 2.00 6.00 7.50 33 28 73
Operating Revenue		 9.28 0.71 0.00 18 0.00 2.00 6.00 7.50 33 28 73
Total Cost of Revenue		 1.63 0.22 0.00 1.03 0.00 0.06 0.68 0.98 2.00 7.93 9.25
Operating Cost of Revenue		 1.63 0.22 0.00 1.03 0.00 0.06 0.68 0.98 2.00 7.93 9.25
Total Operating Expenses		 29 33 37 40 29 33 40 42 44 35 32
Selling, General & Admin Expense		 6.01 7.35 7.63 8.04 8.41 9.81 11 10 9.73 9.44 8.89
Research & Development Expense		 23 26 30 32 20 24 30 32 35 25 23
Total Other Income / (Expense), net		 1.15 1.10 0.34 0.63 0.82 1.80 0.87 1.74 3.21 5.18 4.07
Other Income / (Expense), net		 1.15 1.10 0.34 0.63 0.82 1.80 0.87 1.74 3.21 5.18 4.07
Income Tax Expense		 0.39 0.02 0.00 0.00 -0.72 0.00 0.00 0.06 8.97 4.52 0.05
Basic Earnings per Share		 ($0.40) ($0.62) ($0.72) ($0.41) ($0.43) ($0.37) ($0.41) ($0.39) ($0.21) ($0.16) $0.38
Weighted Average Basic Shares Outstanding		 50.44M 50.86M 51.18M 55.28M 63.64M 79.59M 84.20M 86.56M 87.63M 89.53M 93.43M
Diluted Earnings per Share		 ($0.40) ($0.62) ($0.72) ($0.41) ($0.43) ($0.37) ($0.41) ($0.39) ($0.21) ($0.16) $0.38
Weighted Average Diluted Shares Outstanding		 50.44M 50.86M 51.18M 55.28M 63.64M 79.59M 84.20M 86.56M 87.63M 89.53M 93.82M
Weighted Average Basic & Diluted Shares Outstanding		 50.57M 51.13M 51.29M 59.85M 67.92M 83.68M 86.43M 86.62M 89.24M 89.54M 94.55M

Quarterly Income Statements for Compugen

No quarterly income statements for Compugen are available.

Annual Cash Flow Statements for Compugen

This table details how cash moves in and out of Compugen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -14 -1.15 16 -20 3.37 -2.03 0.70 2.91 2.83 3.97 72
Net Cash From Operating Activities		 -26 -20 -31 -13 -28 -28 -23 -34 -36 50 32
Net Cash From Continuing Operating Activities		 -26 -20 -31 -13 -28 -28 -23 -34 -36 50 32
Net Income / (Loss) Continuing Operations		 -20 -32 -37 -23 -27 -30 -34 -34 -19 -14 35
Consolidated Net Income / (Loss)		 -20 -32 -37 -23 -27 -30 -34 -34 -19 -14 35
Depreciation Expense		 1.11 1.48 1.59 1.39 0.99 0.72 0.46 0.48 0.48 0.49 0.48
Amortization Expense		 -0.42 - 0.25 -0.29 0.07 -0.53 0.00 0.00 -0.28 -1.58 -0.49
Non-Cash Adjustments To Reconcile Net Income		 3.10 11 2.60 2.26 4.42 3.42 5.23 4.73 4.04 2.57 2.23
Changes in Operating Assets and Liabilities, net		 -9.22 -0.70 1.97 5.94 -6.02 -2.22 5.83 -5.63 -21 62 -5.93
Net Cash From Investing Activities		 10 16 46 -35 5.33 -82 6.62 37 36 -46 30
Net Cash From Continuing Investing Activities		 10 16 46 -35 5.33 -82 6.62 37 36 -46 30
Purchase of Property, Plant & Equipment		 -3.12 -2.60 -0.39 -0.16 -0.16 -0.17 -0.29 -0.48 -0.17 -0.12 -0.31
Purchase of Investments		 -34 -51 -25 -62 -54 -152 -130 -77 -54 -160 -96
Sale of Property, Plant & Equipment		 - 0.00 0.00 0.00 0.38 0.04 0.00 -0.01 0.00 0.00 0.00
Sale and/or Maturity of Investments		 47 69 72 27 59 70 137 114 89 114 126
Net Cash From Financing Activities		 0.97 2.46 0.20 28 26 108 17 0.35 3.08 0.55 11
Net Cash From Continuing Financing Activities		 0.97 2.46 0.20 28 26 108 17 0.35 3.08 0.55 11
Issuance of Common Equity		 0.00 0.00 0.00 28 23 74 15 0.00 3.08 0.54 11
Other Financing Activities, net		 0.97 2.46 0.20 0.69 3.17 34 1.88 0.35 0.00 0.01 0.07
Effect of Exchange Rate Changes		 - - - - - - -0.06 -0.39 0.13 0.07 0.14
Cash Income Taxes Paid		 0.00 0.02 - - - - - - 0.01 14 0.06

Quarterly Cash Flow Statements for Compugen

No quarterly cash flow statements for Compugen are available.

Annual Balance Sheets for Compugen

This table presents Compugen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 99 71 39 53 54 138 132 94 121 115 157
Total Current Assets		 91 63 31 47 45 129 123 86 115 106 148
Cash & Equivalents		 11 9.71 25 5.86 9.19 7.14 7.80 11 14 18 91
Short-Term Investments		 70 51 3.92 39 34 117 109 72 37 85 55
Prepaid Expenses		 1.35 1.15 0.74 0.90 1.12 2.66 5.46 2.42 2.53 2.74 2.38
Plant, Property, & Equipment, net		 6.03 5.97 4.65 3.37 2.34 1.71 1.66 1.53 1.22 0.85 0.68
Total Noncurrent Assets		 2.28 2.49 2.92 3.23 6.43 7.52 7.28 6.52 5.54 8.15 7.87
Other Noncurrent Operating Assets		 2.28 2.49 2.92 3.23 6.43 7.52 7.28 6.52 5.54 8.15 7.87
Total Liabilities & Shareholders' Equity		 99 71 39 53 54 138 132 94 121 115 157
Total Liabilities		 9.41 7.62 9.45 16 15 19 25 16 56 60 54
Total Current Liabilities		 6.85 4.74 6.19 9.99 6.82 11 17 12 26 20 23
Accounts Payable		 6.54 4.74 6.19 8.90 5.45 9.22 13 11 3.50 1.84 2.35
Accrued Expenses		 - - - - - - - - 7.86 5.17 5.68
Current Deferred Revenue		 0.31 0.00 0.00 1.09 0.77 0.67 3.63 0.33 11 9.63 11
Current Employee Benefit Liabilities		 - - - - - - - - 3.13 3.07 3.05
Other Current Liabilities		 - - 0.00 0.00 0.60 0.64 0.77 0.61 0.63 0.45 0.52
Total Noncurrent Liabilities		 2.56 2.88 3.26 5.95 8.62 8.01 8.37 4.58 30 40 31
Noncurrent Deferred Revenue		 - - - - - - - 0.00 25 34 25
Noncurrent Employee Benefit Liabilities		 2.56 2.88 3.26 2.95 2.95 3.52 3.68 3.27 3.40 3.41 3.89
Other Noncurrent Operating Liabilities		 - - 0.00 3.00 5.67 4.50 4.70 1.31 0.72 2.46 2.44
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 90 64 29 37 38 120 107 78 66 55 103
Total Preferred & Common Equity		 90 64 29 37 38 120 107 78 66 55 103
Total Common Equity		 90 64 29 37 38 120 107 78 66 55 103
Common Stock		 329 334 338 368 396 508 529 533 540 544 556
Retained Earnings		 -239 -271 -308 -331 -358 -388 -422 -456 -475 -489 -453
Accumulated Other Comprehensive Income / (Loss)		 0.42 0.01 0.02 0.00 0.00 - - 0.00 0.00 0.01 0.01

Quarterly Balance Sheets for Compugen

No quarterly balance sheets for Compugen are available.

Annual Metrics And Ratios for Compugen

This table displays calculated financial ratios and metrics derived from Compugen's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - 51,131,534.00 51,293,070.00 59,849,784.00 67,922,836.00 83,675,856.00 172,866,864.00 173,249,286.00 89,237,465.00 - 94,553,191.00
DEI Adjusted Shares Outstanding		 - 51,131,534.00 51,293,070.00 59,849,784.00 67,922,836.00 83,675,856.00 172,866,864.00 173,249,286.00 89,237,465.00 - 94,553,191.00
DEI Earnings Per Adjusted Shares Outstanding		 - -0.62 -0.72 -0.38 -0.40 -0.35 -0.20 -0.19 -0.21 - 0.37
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -15 -23 -26 -16 -20 -22 -25 -25 -9.09 -10 31
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -31.88% -13.87% -18.98% 30.45%
Earnings before Interest and Taxes (EBIT)		 -20 -31 -37 -23 -28 -30 -34 -34 -9.78 -9.71 35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -19 -30 -35 -21 -27 -30 -34 -33 -9.59 -11 35
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -26 -17 -23 -8.97 -23 -23 -18 -30 -30 52 26
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 8.05 1.99 -1.14 -8.43 -5.56 -4.65 -11 -6.03 15 -48 -43
Increase / (Decrease) in Invested Capital		 11 -6.06 -3.13 -7.29 2.87 0.91 -6.42 5.04 21 -63 5.43
Book Value per Share		 $1.79 $1.26 $0.57 $0.73 $0.64 $1.76 $1.28 $0.90 $0.76 $0.62 $1.15
Tangible Book Value per Share		 $1.79 $1.26 $0.57 $0.73 $0.64 $1.76 $1.28 $0.90 $0.76 $0.62 $1.15
Total Capital		 90 64 29 37 38 120 107 78 66 55 103
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -82 -62 -30 -46 -44 -124 -118 -84 -51 -103 -146
Capital Expenditures (CapEx)		 3.12 2.60 0.39 0.16 -0.23 0.12 0.29 0.49 0.17 0.12 0.31
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 2.30 -3.59 -5.45 -9.09 -5.70 -5.87 -12 -9.50 37 -17 -20
Debt-free Net Working Capital (DFNWC)		 84 58 25 37 38 119 106 74 88 86 125
Net Working Capital (NWC)		 84 58 25 37 38 119 106 74 88 86 125
Net Nonoperating Expense (NNE)		 5.52 8.70 11 6.34 7.12 7.65 9.65 8.93 9.66 3.81 -4.06
Net Nonoperating Obligations (NNO)		 -82 -62 -30 -46 -44 -124 -118 -84 -51 -103 -146
Total Depreciation and Amortization (D&A)		 0.69 1.48 1.84 1.11 1.06 0.18 0.46 0.48 0.20 -1.09 -0.01
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.40) ($0.62) ($0.72) ($0.41) ($0.43) ($0.37) $0.00 $0.00 ($0.21) ($0.16) $0.38
Adjusted Weighted Average Basic Shares Outstanding		 50.44M 50.86M 51.18M 55.28M 63.64M 79.59M 0.00 0.00 87.63M 89.53M 93.43M
Adjusted Diluted Earnings per Share		 ($0.40) ($0.62) ($0.72) ($0.41) ($0.43) ($0.37) $0.00 $0.00 ($0.21) ($0.16) $0.38
Adjusted Weighted Average Diluted Shares Outstanding		 50.44M 50.86M 51.18M 55.28M 63.64M 79.59M 0.00 0.00 87.63M 89.53M 93.82M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 50.57M 51.13M 51.29M 59.85M 67.92M 83.68M 0.00 0.00 89.24M 89.54M 94.55M
Normalized Net Operating Profit after Tax (NOPAT)		 -15 -23 -26 -16 -20 -22 -25 -25 -9.09 -10 31
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Compugen

No quarterly metrics and ratios for Compugen are available.


Financials Breakdown Chart

Compugen Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Compugen's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Compugen's net income appears to be on a downward trend, with a most recent value of $35.34 million in 2025, falling from -$20.16 million in 2015. The previous period was -$14.23 million in 2024. Check out Compugen's forecast to explore projected trends and price targets.

Compugen's total operating income in 2025 was $31.33 million, based on the following breakdown:
  • Total Gross Profit: $63.51 million
  • Total Operating Expenses: $32.19 million

Over the last 10 years, Compugen's total revenue changed from $9.28 million in 2015 to $72.76 million in 2025, a change of 684.3%.

Compugen's total liabilities were at $53.84 million at the end of 2025, a 10.4% decrease from 2024, and a 472.1% increase since 2015.

In the past 10 years, Compugen's cash and equivalents has ranged from $5.86 million in 2018 to $90.60 million in 2025, and is currently $90.60 million as of their latest financial filing in 2025.

Over the last 10 years, Compugen's book value per share changed from 1.79 in 2015 to 1.15 in 2025, a change of -35.9%.


Related Companies

Financial statements for NASDAQ:CGEN last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel